Koning Breast CT vs. Mammogam: A Review of Recent Port Orange Screening Trial

Koning’s breast CT device has momentous benefits over traditional modalities. In a Port Orange Screening trial, women’s experiences were examined compared to mammography specifically.

The data acquired in the clinical trial covered the typical screening population of women who are 40 years and older. The analysis of the patient feedback demonstrated that the KBCT System, version 2.0, is significantly more comfortable when compared with breast compression that occurs with screening mammography.

The exam time of the KBCT is also much less than the exam time required for mammography. In addition to the comfort level and exam time, patients found distinct advantages in residing prone instead of standing for 10 plus minutes during the scan. 

The KBCT System has been successfully used since its approval in 2013. Further, the group of healthcare professionals who had never used the System were able to be trained and successfully operate and perform the breast scans for their patients.

Read the full review here: https://www.koninghealth.com/news-insights/81-press-releases/108-koning-begins-fda-clinical-screening-trial-in-daytona-beach-florida